1 / 8

PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

Plasma Lipoprotein and Apo Levels at Baseline and Lipoprotein Levels on Treatment in Pravastatin-Treated Subjects in PROSPER. PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065. Relation between baseline lipoprotein levels and incidence of the primary end point.

micah-little
Download Presentation

PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Plasma Lipoprotein and Apo Levels at Baseline and Lipoprotein Levels on Treatment in Pravastatin-Treated Subjects in PROSPER PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

  2. Relation between baseline lipoprotein levels and incidence of the primary end point PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

  3. RR of primary end point by quintile of baseline LDLc and baseline HDLc PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

  4. Pravastatin Treatment Effect by Quintile (Q) of Baseline Lipoprotein Levels PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

  5. Relation between on-treatment lipoprotein levels and risk of the primary end point PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

  6. Lipoprotein Variables in Models of Outcome in the Whole PROSPER Cohort - Part I PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

  7. Lipoprotein Variables in Models of Outcome in the Whole PROSPER Cohort - Part II PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

  8. Representative Multivariate Model of Treatment Effect on Lipid Levels* PROSPER Study C.J. Packard et al, Circulation 2005; 112: 3058-3065

More Related